Article info

Download PDFPDF

Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD)

Authors

  1. Correspondence to Dr Iain Parry Hargreaves; i.hargreaves{at}ucl.ac.uk
View Full Text

Citation

Porter KMF, Hargreaves IP, De Souza S, et al
Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD)

Publication history

  • Accepted January 13, 2021
  • First published March 8, 2021.
Online issue publication 
March 08, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.